ENZO BIOCHEM INC 4
4 · ENZO BIOCHEM INC · Filed Aug 13, 2007
Insider Transaction Report
Form 4
GOLDBERG DAVID C
VP, Corporate Development
Transactions
- Conversion
Employee Stock Option
2007-08-09−3,191→ 54,719 totalExercise: $11.65From: 1997-08-27Exp: 2007-08-27→ Common Stock, par value $0.01 per share (3,191 underlying) - Conversion
Common Stock, par value $0.01 per share
2007-08-09+3,191→ 99,654 total
Footnotes (2)
- [F1]The Reporting Person exercised a stock option to purchase 3,191 shares of Common Stock and paid the exercise price thereof by the surrender of 2,082 shares of Common Stock, for a net gain in outstanding shares of Common Stock of 1,109 shares. The stated exercise price of the stock options was $11.655.
- [F2]As of the date hereof, the Reporting Person directly beneficially owned 40,854 shares of Common Stock, 979 shares indirectly beneficially owned through the UGMA accounts of the Reporting Person's children, 3,102 shares of Common Stock in Enzo Biochem's 401(K) Plan and 54,719 options to purchase Common Stock, par value $0.01 per share, which are currently exercisable.